Extracellular Vesicles and Alveolar Epithelial-Capillary Barrier Disruption in Acute Respiratory Distress Syndrome: Pathophysiological Role and Therapeutic Potential

被引：15
作者：
Esquivel-Ruiz, Sergio [1 ,2 ]
Gonzalez-Rodriguez, Paloma [2 ,3 ]
Lorente, Jose A. [2 ,3 ,4 ]
Perez-Vizcaino, Francisco [1 ,2 ]
Herrero, Raquel [2 ,3 ]
Moreno, Laura [1 ,2 ]
机构：
[1] Univ Complutense Madrid, Sch Med, Inst Invest Sanit Gregorio Maranon IiSGM, Dept Pharmacol & Toxicol, Madrid, Spain
[2] Ciber Enfermedades Resp CIBERES, Madrid, Spain
[3] Hosp Univ Getafe, Dept Crit Care, Madrid, Spain
[4] European Univ Madrid, Sch Med, Clin Sect, Madrid, Spain
来源：
FRONTIERS IN PHYSIOLOGY | 2021年 / 12卷
关键词：
barrier dysfunction; airway epithelium; pulmonary endothelium; mesenchymal stem cells; extracellular vesicles (EVs); preconditioning; MESENCHYMAL STEM-CELLS; ACUTE LUNG INJURY; TISSUE FACTOR ACTIVITY; DISSEMINATED INTRAVASCULAR COAGULATION; NF-KAPPA-B; STROMAL CELLS; ENDOTHELIAL-CELLS; INTERFERON-GAMMA; FLUID CLEARANCE; IN-VITRO;
D O I：
10.3389/fphys.2021.752287
中图分类号：
Q4 [生理学];
学科分类号：
071003 ;
摘要：
Extracellular vesicles (EVs) mediate intercellular communication by transferring genetic material, proteins and organelles between different cells types in both health and disease. Recent evidence suggests that these vesicles, more than simply diagnostic markers, are key mediators of the pathophysiology of acute respiratory distress syndrome (ARDS) and other lung diseases. In this review, we will discuss the contribution of EVs released by pulmonary structural cells (alveolar epithelial and endothelial cells) and immune cells in these diseases, with particular attention to their ability to modulate inflammation and alveolar-capillary barrier disruption, a hallmark of ARDS. EVs also offer a unique opportunity to develop new therapeutics for the treatment of ARDS. Evidences supporting the ability of stem cell-derived EVs to attenuate the lung injury and ongoing strategies to improve their therapeutic potential are also discussed.
引用
收藏
页数：28
相关论文
共 50 条
[41]   Exploring m6A-RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome [J].
Faraj, Reem ;
Liang, Ying ;
Feng, Anlin ;
Wu, Jialin ;
Black, Stephen M. ;
Wang, Ting .
PULMONARY CIRCULATION, 2023, 13 (02)
[42]   Human Placental Mesenchymal Stem Cells and Derived Extracellular Vesicles Ameliorate Lung Injury in Acute Respiratory Distress Syndrome Murine Model [J].
Valiukevicius, Paulius ;
Maciulaitis, Justinas ;
Pangonyte, Dalia ;
Sirataviciute, Vitalija ;
Kluszczynska, Katarzyna ;
Kuzaityte, Ugne ;
Insodaite, Ruta ;
Ciapiene, Ieva ;
Grigaleviciute, Ramune ;
Zigmantaite, Vilma ;
Vitkauskiene, Astra ;
Maciulaitis, Romaldas .
CELLS, 2023, 12 (23)
[43]   REDUCING THE BURDEN OF ACUTE RESPIRATORY DISTRESS SYNDROME: THE CASE FOR EARLY INTERVENTION AND THE POTENTIAL ROLE OF THE EMERGENCY DEPARTMENT [J].
Fuller, Brian M. ;
Mohr, Nicholas M. ;
Hotchkiss, Richard S. ;
Kollef, Marin H. .
SHOCK, 2014, 41 (05) :378-387
[44]   Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: Role of platelet-derived growth factor pathway [J].
Piednoir, Pascale ;
Quesnel, Christophe ;
Nardelli, Laurent ;
Lecon, Veronique ;
Bouadma, Lila ;
Lasocki, Sigismond ;
Philip, Ivan ;
Mailleux, Arnaud ;
Soler, Paul ;
Crestani, Bruno ;
Dehoux, Monique .
CRITICAL CARE MEDICINE, 2012, 40 (07) :2041-2049
[45]   Potential therapeutic effects and nano-based delivery systems of mesenchymal stem cells and their isolated exosomes to alleviate acute respiratory distress syndrome caused by COVID-19 [J].
Ghiasi, Mohsen ;
Zarandi, Peyman Kheirandish ;
Dayani, Abdolreza ;
Salimi, Ali ;
Shokri, Ehsan .
REGENERATIVE THERAPY, 2024, 27 :319-328
[46]   Therapeutic Potential of Mesenchymal Stem Cells and Their Secretome in the Treatment of SARS-CoV-2-Induced Acute Respiratory Distress Syndrome [J].
Harrell, Carl Randall ;
Jovicic, Biljana Popovska ;
Djonov, Valentin ;
Volarevic, Vladislav .
ANALYTICAL CELLULAR PATHOLOGY, 2020, 2020
[47]   Necrosis Rather Than Apoptosis is the Dominant form of Alveolar Epithelial Cell Death in Lipopolysaccharide-Induced Experimental Acute Respiratory Distress Syndrome Model [J].
Tamada, Nao ;
Tojo, Kentaro ;
Yazawa, Takuya ;
Goto, Takahisa .
SHOCK, 2020, 54 (01) :128-139
[48]   Biomarker profiles of coagulopathy and alveolar epithelial injury in acute respiratory distress syndrome with idiopathic/immune-related disease or common direct risk factors [J].
Koyama, Kansuke ;
Katayama, Shinshu ;
Tonai, Ken ;
Shima, Jun ;
Koinuma, Toshitaka ;
Nunomiya, Shin .
CRITICAL CARE, 2019, 23 (01)
[49]   The Synergistic Role of P2rx7 and Panx1 in Regulating Alveolar Macrophage Pyroptosis and Exosome-Mediated Ferroptosis of Alveolar Epithelial Cells in Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome [J].
Rao, Haiyan ;
Ding, Qunhua ;
Liu, Annan ;
Qiu, Huijun ;
Luo, Jinghua .
FASEB JOURNAL, 2025, 39 (16)
[50]   Emerging Mechanisms of Pulmonary Vasoconstriction in SARS-CoV-2-Induced Acute Respiratory Distress Syndrome (ARDS) and Potential Therapeutic Targets [J].
Karmouty-Quintana, Harry ;
Thandavarayan, Rajarajan A. ;
Keller, Steven P. ;
Sahay, Sandeep ;
Pandit, Lavannya M. ;
Akkanti, Bindu .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (21) :1-21
12345